nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A4—Cimetidine—obesity	0.176	0.272	CbGbCtD
Ipratropium bromide—SLC22A5—Methamphetamine—obesity	0.127	0.197	CbGbCtD
Ipratropium bromide—SLC22A5—Cimetidine—obesity	0.0994	0.154	CbGbCtD
Ipratropium bromide—CYP2D6—Phentermine—obesity	0.0381	0.059	CbGbCtD
Ipratropium bromide—CYP2D6—Bupropion—obesity	0.0324	0.0501	CbGbCtD
Ipratropium bromide—CYP3A4—Sibutramine—obesity	0.032	0.0495	CbGbCtD
Ipratropium bromide—CYP2D6—Methamphetamine—obesity	0.0304	0.0471	CbGbCtD
Ipratropium bromide—CYP3A4—Benzphetamine—obesity	0.0242	0.0375	CbGbCtD
Ipratropium bromide—CYP2D6—Cimetidine—obesity	0.0238	0.0368	CbGbCtD
Ipratropium bromide—CYP3A4—Bupropion—obesity	0.0206	0.0319	CbGbCtD
Ipratropium bromide—CYP3A4—Orlistat—obesity	0.0168	0.026	CbGbCtD
Ipratropium bromide—CYP3A4—Cimetidine—obesity	0.0151	0.0234	CbGbCtD
Ipratropium bromide—CYP3A4—Topiramate—obesity	0.00989	0.0153	CbGbCtD
Ipratropium bromide—CHRM3—muscle of abdomen—obesity	0.00451	0.302	CbGeAlD
Ipratropium bromide—Cyclandelate—CES1—obesity	0.003	0.733	CrCbGaD
Ipratropium bromide—SLC22A4—respiratory system—obesity	0.000813	0.0545	CbGeAlD
Ipratropium bromide—CHRM2—cardiovascular system—obesity	0.000603	0.0405	CbGeAlD
Ipratropium bromide—CYP2D6—hindbrain—obesity	0.000568	0.0381	CbGeAlD
Ipratropium bromide—SLC22A4—pituitary gland—obesity	0.000551	0.037	CbGeAlD
Ipratropium bromide—CHRM1—cardiovascular system—obesity	0.000549	0.0369	CbGeAlD
Ipratropium bromide—SLC22A4—adipose tissue—obesity	0.000549	0.0368	CbGeAlD
Ipratropium bromide—Dexmethylphenidate—SLC6A4—obesity	0.000547	0.134	CrCbGaD
Ipratropium bromide—Methylphenidate—SLC6A4—obesity	0.000547	0.134	CrCbGaD
Ipratropium bromide—SLC22A5—respiratory system—obesity	0.000538	0.0361	CbGeAlD
Ipratropium bromide—SLC22A4—digestive system—obesity	0.000517	0.0347	CbGeAlD
Ipratropium bromide—SLC22A4—adrenal gland—obesity	0.000492	0.033	CbGeAlD
Ipratropium bromide—SLC22A5—adrenal cortex—obesity	0.000451	0.0303	CbGeAlD
Ipratropium bromide—CHRM3—adipose tissue—obesity	0.000433	0.0291	CbGeAlD
Ipratropium bromide—CHRM2—endocrine gland—obesity	0.000414	0.0278	CbGeAlD
Ipratropium bromide—CHRM3—digestive system—obesity	0.000408	0.0274	CbGeAlD
Ipratropium bromide—CHRM1—endocrine gland—obesity	0.000377	0.0253	CbGeAlD
Ipratropium bromide—Haemorrhage—Sibutramine—obesity	0.000373	0.00186	CcSEcCtD
Ipratropium bromide—Nausea—Phenylpropanolamine—obesity	0.000372	0.00185	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Sibutramine—obesity	0.000371	0.00185	CcSEcCtD
Ipratropium bromide—Pharyngitis—Sibutramine—obesity	0.00037	0.00185	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Cimetidine—obesity	0.000366	0.00182	CcSEcCtD
Ipratropium bromide—SLC22A5—pituitary gland—obesity	0.000365	0.0245	CbGeAlD
Ipratropium bromide—SLC22A5—adipose tissue—obesity	0.000363	0.0244	CbGeAlD
Ipratropium bromide—Abnormal vision—Topiramate—obesity	0.00036	0.00179	CcSEcCtD
Ipratropium bromide—Visual impairment—Sibutramine—obesity	0.00036	0.00179	CcSEcCtD
Ipratropium bromide—Diarrhoea—Diethylpropion—obesity	0.000357	0.00178	CcSEcCtD
Ipratropium bromide—Nausea—Phentermine—obesity	0.000356	0.00177	CcSEcCtD
Ipratropium bromide—Asthenia—Cimetidine—obesity	0.000356	0.00177	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Bupropion—obesity	0.000355	0.00177	CcSEcCtD
Ipratropium bromide—Stomatitis—Bupropion—obesity	0.000353	0.00176	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Bupropion—obesity	0.000352	0.00175	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Bupropion—obesity	0.000352	0.00175	CcSEcCtD
Ipratropium bromide—Eye disorder—Sibutramine—obesity	0.000349	0.00174	CcSEcCtD
Ipratropium bromide—Immune system disorder—Orlistat—obesity	0.000348	0.00174	CcSEcCtD
Ipratropium bromide—Tinnitus—Sibutramine—obesity	0.000348	0.00173	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Orlistat—obesity	0.000348	0.00173	CcSEcCtD
Ipratropium bromide—Sweating—Bupropion—obesity	0.000348	0.00173	CcSEcCtD
Ipratropium bromide—Dizziness—Diethylpropion—obesity	0.000345	0.00172	CcSEcCtD
Ipratropium bromide—SLC22A5—digestive system—obesity	0.000342	0.0229	CbGeAlD
Ipratropium bromide—Epistaxis—Bupropion—obesity	0.000342	0.0017	CcSEcCtD
Ipratropium bromide—Sinusitis—Bupropion—obesity	0.00034	0.00169	CcSEcCtD
Ipratropium bromide—Diarrhoea—Cimetidine—obesity	0.00034	0.00169	CcSEcCtD
Ipratropium bromide—CHRM3—endocrine gland—obesity	0.000337	0.0226	CbGeAlD
Ipratropium bromide—Immune system disorder—Sibutramine—obesity	0.000337	0.00168	CcSEcCtD
Ipratropium bromide—Eye pain—Topiramate—obesity	0.000332	0.00165	CcSEcCtD
Ipratropium bromide—Vomiting—Diethylpropion—obesity	0.000332	0.00165	CcSEcCtD
Ipratropium bromide—Flatulence—Orlistat—obesity	0.000331	0.00165	CcSEcCtD
Ipratropium bromide—Nasal congestion—Topiramate—obesity	0.000329	0.00164	CcSEcCtD
Ipratropium bromide—Rash—Diethylpropion—obesity	0.000329	0.00164	CcSEcCtD
Ipratropium bromide—Dysgeusia—Orlistat—obesity	0.000329	0.00164	CcSEcCtD
Ipratropium bromide—Dermatitis—Diethylpropion—obesity	0.000329	0.00164	CcSEcCtD
Ipratropium bromide—Dizziness—Cimetidine—obesity	0.000328	0.00163	CcSEcCtD
Ipratropium bromide—Haemoglobin—Bupropion—obesity	0.000327	0.00163	CcSEcCtD
Ipratropium bromide—Headache—Diethylpropion—obesity	0.000327	0.00163	CcSEcCtD
Ipratropium bromide—Rhinitis—Bupropion—obesity	0.000326	0.00162	CcSEcCtD
Ipratropium bromide—SLC22A5—adrenal gland—obesity	0.000326	0.0219	CbGeAlD
Ipratropium bromide—Haemorrhage—Bupropion—obesity	0.000325	0.00162	CcSEcCtD
Ipratropium bromide—Back pain—Orlistat—obesity	0.000325	0.00162	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Bupropion—obesity	0.000324	0.00161	CcSEcCtD
Ipratropium bromide—Pharyngitis—Bupropion—obesity	0.000323	0.00161	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Bupropion—obesity	0.000321	0.0016	CcSEcCtD
Ipratropium bromide—Flatulence—Sibutramine—obesity	0.00032	0.00159	CcSEcCtD
Ipratropium bromide—Urethral disorder—Bupropion—obesity	0.000319	0.00159	CcSEcCtD
Ipratropium bromide—Tension—Sibutramine—obesity	0.000319	0.00159	CcSEcCtD
Ipratropium bromide—Dysgeusia—Sibutramine—obesity	0.000318	0.00158	CcSEcCtD
Ipratropium bromide—Vision blurred—Orlistat—obesity	0.000316	0.00158	CcSEcCtD
Ipratropium bromide—Nervousness—Sibutramine—obesity	0.000316	0.00157	CcSEcCtD
Ipratropium bromide—Vomiting—Cimetidine—obesity	0.000316	0.00157	CcSEcCtD
Ipratropium bromide—Thirst—Topiramate—obesity	0.000315	0.00157	CcSEcCtD
Ipratropium bromide—Back pain—Sibutramine—obesity	0.000314	0.00157	CcSEcCtD
Ipratropium bromide—Visual impairment—Bupropion—obesity	0.000314	0.00156	CcSEcCtD
Ipratropium bromide—Rash—Cimetidine—obesity	0.000313	0.00156	CcSEcCtD
Ipratropium bromide—Dermatitis—Cimetidine—obesity	0.000313	0.00156	CcSEcCtD
Ipratropium bromide—Headache—Cimetidine—obesity	0.000311	0.00155	CcSEcCtD
Ipratropium bromide—Nausea—Diethylpropion—obesity	0.00031	0.00154	CcSEcCtD
Ipratropium bromide—Angioedema—Orlistat—obesity	0.000307	0.00153	CcSEcCtD
Ipratropium bromide—Vision blurred—Sibutramine—obesity	0.000306	0.00153	CcSEcCtD
Ipratropium bromide—Tremor—Sibutramine—obesity	0.000304	0.00152	CcSEcCtD
Ipratropium bromide—Eye disorder—Bupropion—obesity	0.000304	0.00151	CcSEcCtD
Ipratropium bromide—Tinnitus—Bupropion—obesity	0.000303	0.00151	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Bupropion—obesity	0.000302	0.0015	CcSEcCtD
Ipratropium bromide—Flushing—Bupropion—obesity	0.000302	0.0015	CcSEcCtD
Ipratropium bromide—Angioedema—Sibutramine—obesity	0.000297	0.00148	CcSEcCtD
Ipratropium bromide—Palpitations—Orlistat—obesity	0.000297	0.00148	CcSEcCtD
Ipratropium bromide—Nausea—Cimetidine—obesity	0.000295	0.00147	CcSEcCtD
Ipratropium bromide—Immune system disorder—Bupropion—obesity	0.000294	0.00146	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Bupropion—obesity	0.000293	0.00146	CcSEcCtD
Ipratropium bromide—Cough—Orlistat—obesity	0.000293	0.00146	CcSEcCtD
Ipratropium bromide—Palpitations—Sibutramine—obesity	0.000287	0.00143	CcSEcCtD
Ipratropium bromide—Chest pain—Orlistat—obesity	0.000286	0.00142	CcSEcCtD
Ipratropium bromide—Myalgia—Orlistat—obesity	0.000286	0.00142	CcSEcCtD
Ipratropium bromide—Urinary retention—Topiramate—obesity	0.000285	0.00142	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000284	0.00141	CcSEcCtD
Ipratropium bromide—Cough—Sibutramine—obesity	0.000284	0.00141	CcSEcCtD
Ipratropium bromide—Hypertension—Sibutramine—obesity	0.000281	0.0014	CcSEcCtD
Ipratropium bromide—Dry mouth—Orlistat—obesity	0.00028	0.00139	CcSEcCtD
Ipratropium bromide—Flatulence—Bupropion—obesity	0.000279	0.00139	CcSEcCtD
Ipratropium bromide—Tension—Bupropion—obesity	0.000278	0.00138	CcSEcCtD
Ipratropium bromide—Dysgeusia—Bupropion—obesity	0.000277	0.00138	CcSEcCtD
Ipratropium bromide—Chest pain—Sibutramine—obesity	0.000277	0.00138	CcSEcCtD
Ipratropium bromide—Myalgia—Sibutramine—obesity	0.000277	0.00138	CcSEcCtD
Ipratropium bromide—Nervousness—Bupropion—obesity	0.000275	0.00137	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Orlistat—obesity	0.000274	0.00136	CcSEcCtD
Ipratropium bromide—Oedema—Orlistat—obesity	0.000274	0.00136	CcSEcCtD
Ipratropium bromide—Back pain—Bupropion—obesity	0.000274	0.00136	CcSEcCtD
Ipratropium bromide—Infection—Orlistat—obesity	0.000272	0.00136	CcSEcCtD
Ipratropium bromide—Dry mouth—Sibutramine—obesity	0.000271	0.00135	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Orlistat—obesity	0.000269	0.00134	CcSEcCtD
Ipratropium bromide—Vision blurred—Bupropion—obesity	0.000267	0.00133	CcSEcCtD
Ipratropium bromide—Skin disorder—Orlistat—obesity	0.000266	0.00133	CcSEcCtD
Ipratropium bromide—Tremor—Bupropion—obesity	0.000265	0.00132	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Sibutramine—obesity	0.000265	0.00132	CcSEcCtD
Ipratropium bromide—Oedema—Sibutramine—obesity	0.000265	0.00132	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Orlistat—obesity	0.000265	0.00132	CcSEcCtD
Ipratropium bromide—Infection—Sibutramine—obesity	0.000263	0.00131	CcSEcCtD
Ipratropium bromide—Dysphagia—Topiramate—obesity	0.000259	0.00129	CcSEcCtD
Ipratropium bromide—Asthma—Topiramate—obesity	0.000259	0.00129	CcSEcCtD
Ipratropium bromide—Angioedema—Bupropion—obesity	0.000259	0.00129	CcSEcCtD
Ipratropium bromide—Tachycardia—Sibutramine—obesity	0.000259	0.00129	CcSEcCtD
Ipratropium bromide—Skin disorder—Sibutramine—obesity	0.000258	0.00128	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Sibutramine—obesity	0.000256	0.00128	CcSEcCtD
Ipratropium bromide—SLC22A5—liver—obesity	0.000255	0.0171	CbGeAlD
Ipratropium bromide—Palpitations—Bupropion—obesity	0.00025	0.00125	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Orlistat—obesity	0.00025	0.00124	CcSEcCtD
Ipratropium bromide—Bronchitis—Topiramate—obesity	0.000249	0.00124	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Topiramate—obesity	0.000248	0.00124	CcSEcCtD
Ipratropium bromide—Insomnia—Orlistat—obesity	0.000248	0.00123	CcSEcCtD
Ipratropium bromide—Hypotension—Sibutramine—obesity	0.000248	0.00123	CcSEcCtD
Ipratropium bromide—Cough—Bupropion—obesity	0.000247	0.00123	CcSEcCtD
Ipratropium bromide—Paraesthesia—Orlistat—obesity	0.000246	0.00123	CcSEcCtD
Ipratropium bromide—Hypertension—Bupropion—obesity	0.000245	0.00122	CcSEcCtD
Ipratropium bromide—Dysuria—Topiramate—obesity	0.000242	0.00121	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Sibutramine—obesity	0.000242	0.0012	CcSEcCtD
Ipratropium bromide—Dyspepsia—Orlistat—obesity	0.000241	0.0012	CcSEcCtD
Ipratropium bromide—Chest pain—Bupropion—obesity	0.000241	0.0012	CcSEcCtD
Ipratropium bromide—Myalgia—Bupropion—obesity	0.000241	0.0012	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Topiramate—obesity	0.000241	0.0012	CcSEcCtD
Ipratropium bromide—Insomnia—Sibutramine—obesity	0.00024	0.00119	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00024	0.00119	CcSEcCtD
Ipratropium bromide—Pollakiuria—Topiramate—obesity	0.000239	0.00119	CcSEcCtD
Ipratropium bromide—Paraesthesia—Sibutramine—obesity	0.000238	0.00119	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Orlistat—obesity	0.000237	0.00118	CcSEcCtD
Ipratropium bromide—Dyspnoea—Sibutramine—obesity	0.000236	0.00118	CcSEcCtD
Ipratropium bromide—Fatigue—Orlistat—obesity	0.000236	0.00118	CcSEcCtD
Ipratropium bromide—Dry mouth—Bupropion—obesity	0.000236	0.00117	CcSEcCtD
Ipratropium bromide—Somnolence—Sibutramine—obesity	0.000236	0.00117	CcSEcCtD
Ipratropium bromide—Pain—Orlistat—obesity	0.000234	0.00117	CcSEcCtD
Ipratropium bromide—Dyspepsia—Sibutramine—obesity	0.000233	0.00116	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Bupropion—obesity	0.000231	0.00115	CcSEcCtD
Ipratropium bromide—Oedema—Bupropion—obesity	0.000231	0.00115	CcSEcCtD
Ipratropium bromide—Infection—Bupropion—obesity	0.00023	0.00114	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Sibutramine—obesity	0.000229	0.00114	CcSEcCtD
Ipratropium bromide—Pain—Sibutramine—obesity	0.000227	0.00113	CcSEcCtD
Ipratropium bromide—Constipation—Sibutramine—obesity	0.000227	0.00113	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Bupropion—obesity	0.000227	0.00113	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Topiramate—obesity	0.000226	0.00113	CcSEcCtD
Ipratropium bromide—Tachycardia—Bupropion—obesity	0.000226	0.00112	CcSEcCtD
Ipratropium bromide—Stomatitis—Topiramate—obesity	0.000225	0.00112	CcSEcCtD
Ipratropium bromide—Skin disorder—Bupropion—obesity	0.000225	0.00112	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Topiramate—obesity	0.000224	0.00112	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Topiramate—obesity	0.000224	0.00112	CcSEcCtD
Ipratropium bromide—CYP3A4—digestive system—obesity	0.000224	0.015	CbGeAlD
Ipratropium bromide—Gastrointestinal pain—Orlistat—obesity	0.000224	0.00112	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Bupropion—obesity	0.000223	0.00111	CcSEcCtD
Ipratropium bromide—CYP2D6—digestive system—obesity	0.000221	0.0148	CbGeAlD
Ipratropium bromide—Epistaxis—Topiramate—obesity	0.000218	0.00108	CcSEcCtD
Ipratropium bromide—Urticaria—Orlistat—obesity	0.000218	0.00108	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Sibutramine—obesity	0.000217	0.00108	CcSEcCtD
Ipratropium bromide—Sinusitis—Topiramate—obesity	0.000217	0.00108	CcSEcCtD
Ipratropium bromide—Abdominal pain—Orlistat—obesity	0.000217	0.00108	CcSEcCtD
Ipratropium bromide—Hypotension—Bupropion—obesity	0.000216	0.00108	CcSEcCtD
Ipratropium bromide—Urticaria—Sibutramine—obesity	0.000211	0.00105	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Bupropion—obesity	0.000211	0.00105	CcSEcCtD
Ipratropium bromide—Abdominal pain—Sibutramine—obesity	0.00021	0.00104	CcSEcCtD
Ipratropium bromide—Insomnia—Bupropion—obesity	0.000209	0.00104	CcSEcCtD
Ipratropium bromide—Haemoglobin—Topiramate—obesity	0.000208	0.00104	CcSEcCtD
Ipratropium bromide—Rhinitis—Topiramate—obesity	0.000208	0.00104	CcSEcCtD
Ipratropium bromide—Paraesthesia—Bupropion—obesity	0.000208	0.00103	CcSEcCtD
Ipratropium bromide—Haemorrhage—Topiramate—obesity	0.000207	0.00103	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Topiramate—obesity	0.000206	0.00103	CcSEcCtD
Ipratropium bromide—Dyspnoea—Bupropion—obesity	0.000206	0.00103	CcSEcCtD
Ipratropium bromide—Pharyngitis—Topiramate—obesity	0.000206	0.00102	CcSEcCtD
Ipratropium bromide—Somnolence—Bupropion—obesity	0.000206	0.00102	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Topiramate—obesity	0.000205	0.00102	CcSEcCtD
Ipratropium bromide—Dyspepsia—Bupropion—obesity	0.000204	0.00101	CcSEcCtD
Ipratropium bromide—Urethral disorder—Topiramate—obesity	0.000203	0.00101	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Orlistat—obesity	0.000202	0.00101	CcSEcCtD
Ipratropium bromide—Visual impairment—Topiramate—obesity	0.0002	0.000995	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Bupropion—obesity	0.0002	0.000994	CcSEcCtD
Ipratropium bromide—Fatigue—Bupropion—obesity	0.000199	0.000993	CcSEcCtD
Ipratropium bromide—Pain—Bupropion—obesity	0.000198	0.000985	CcSEcCtD
Ipratropium bromide—Constipation—Bupropion—obesity	0.000198	0.000985	CcSEcCtD
Ipratropium bromide—Asthenia—Orlistat—obesity	0.000197	0.000979	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Sibutramine—obesity	0.000195	0.000973	CcSEcCtD
Ipratropium bromide—Pruritus—Orlistat—obesity	0.000194	0.000966	CcSEcCtD
Ipratropium bromide—Eye disorder—Topiramate—obesity	0.000194	0.000965	CcSEcCtD
Ipratropium bromide—Tinnitus—Topiramate—obesity	0.000193	0.000963	CcSEcCtD
Ipratropium bromide—Flushing—Topiramate—obesity	0.000192	0.000958	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Topiramate—obesity	0.000192	0.000958	CcSEcCtD
Ipratropium bromide—Asthenia—Sibutramine—obesity	0.00019	0.000948	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Bupropion—obesity	0.000189	0.000942	CcSEcCtD
Ipratropium bromide—Pruritus—Sibutramine—obesity	0.000188	0.000934	CcSEcCtD
Ipratropium bromide—Diarrhoea—Orlistat—obesity	0.000187	0.000934	CcSEcCtD
Ipratropium bromide—Immune system disorder—Topiramate—obesity	0.000187	0.000933	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Topiramate—obesity	0.000187	0.000931	CcSEcCtD
Ipratropium bromide—CYP3A4—endocrine gland—obesity	0.000185	0.0124	CbGeAlD
Ipratropium bromide—Urticaria—Bupropion—obesity	0.000184	0.000915	CcSEcCtD
Ipratropium bromide—Abdominal pain—Bupropion—obesity	0.000183	0.00091	CcSEcCtD
Ipratropium bromide—CYP2D6—endocrine gland—obesity	0.000182	0.0122	CbGeAlD
Ipratropium bromide—Diarrhoea—Sibutramine—obesity	0.000181	0.000904	CcSEcCtD
Ipratropium bromide—Dizziness—Orlistat—obesity	0.000181	0.000902	CcSEcCtD
Ipratropium bromide—Flatulence—Topiramate—obesity	0.000178	0.000886	CcSEcCtD
Ipratropium bromide—Tension—Topiramate—obesity	0.000177	0.000882	CcSEcCtD
Ipratropium bromide—Dysgeusia—Topiramate—obesity	0.000177	0.00088	CcSEcCtD
Ipratropium bromide—Dizziness—Sibutramine—obesity	0.000175	0.000873	CcSEcCtD
Ipratropium bromide—Nervousness—Topiramate—obesity	0.000175	0.000873	CcSEcCtD
Ipratropium bromide—Back pain—Topiramate—obesity	0.000175	0.000869	CcSEcCtD
Ipratropium bromide—Vomiting—Orlistat—obesity	0.000174	0.000868	CcSEcCtD
Ipratropium bromide—Rash—Orlistat—obesity	0.000173	0.00086	CcSEcCtD
Ipratropium bromide—Dermatitis—Orlistat—obesity	0.000173	0.00086	CcSEcCtD
Ipratropium bromide—Headache—Orlistat—obesity	0.000172	0.000855	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Bupropion—obesity	0.00017	0.000848	CcSEcCtD
Ipratropium bromide—Vision blurred—Topiramate—obesity	0.00017	0.000847	CcSEcCtD
Ipratropium bromide—Tremor—Topiramate—obesity	0.000169	0.000842	CcSEcCtD
Ipratropium bromide—Vomiting—Sibutramine—obesity	0.000169	0.00084	CcSEcCtD
Ipratropium bromide—Rash—Sibutramine—obesity	0.000167	0.000833	CcSEcCtD
Ipratropium bromide—Dermatitis—Sibutramine—obesity	0.000167	0.000832	CcSEcCtD
Ipratropium bromide—CYP3A4—liver—obesity	0.000167	0.0112	CbGeAlD
Ipratropium bromide—Headache—Sibutramine—obesity	0.000166	0.000827	CcSEcCtD
Ipratropium bromide—Asthenia—Bupropion—obesity	0.000166	0.000826	CcSEcCtD
Ipratropium bromide—CYP2D6—liver—obesity	0.000164	0.011	CbGeAlD
Ipratropium bromide—Pruritus—Bupropion—obesity	0.000164	0.000815	CcSEcCtD
Ipratropium bromide—Nausea—Orlistat—obesity	0.000163	0.000811	CcSEcCtD
Ipratropium bromide—Palpitations—Topiramate—obesity	0.000159	0.000794	CcSEcCtD
Ipratropium bromide—Diarrhoea—Bupropion—obesity	0.000158	0.000788	CcSEcCtD
Ipratropium bromide—Nausea—Sibutramine—obesity	0.000158	0.000785	CcSEcCtD
Ipratropium bromide—Cough—Topiramate—obesity	0.000157	0.000784	CcSEcCtD
Ipratropium bromide—Hypertension—Topiramate—obesity	0.000156	0.000776	CcSEcCtD
Ipratropium bromide—Myalgia—Topiramate—obesity	0.000154	0.000765	CcSEcCtD
Ipratropium bromide—Chest pain—Topiramate—obesity	0.000154	0.000765	CcSEcCtD
Ipratropium bromide—Dizziness—Bupropion—obesity	0.000153	0.000761	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000153	0.00076	CcSEcCtD
Ipratropium bromide—Dry mouth—Topiramate—obesity	0.00015	0.000748	CcSEcCtD
Ipratropium bromide—Oedema—Topiramate—obesity	0.000147	0.000734	CcSEcCtD
Ipratropium bromide—Vomiting—Bupropion—obesity	0.000147	0.000732	CcSEcCtD
Ipratropium bromide—Infection—Topiramate—obesity	0.000146	0.000729	CcSEcCtD
Ipratropium bromide—Rash—Bupropion—obesity	0.000146	0.000726	CcSEcCtD
Ipratropium bromide—Dermatitis—Bupropion—obesity	0.000146	0.000725	CcSEcCtD
Ipratropium bromide—Headache—Bupropion—obesity	0.000145	0.000721	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Topiramate—obesity	0.000144	0.000719	CcSEcCtD
Ipratropium bromide—Tachycardia—Topiramate—obesity	0.000144	0.000716	CcSEcCtD
Ipratropium bromide—Skin disorder—Topiramate—obesity	0.000143	0.000713	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Topiramate—obesity	0.000142	0.000709	CcSEcCtD
Ipratropium bromide—Hypotension—Topiramate—obesity	0.000138	0.000685	CcSEcCtD
Ipratropium bromide—Nausea—Bupropion—obesity	0.000137	0.000684	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Topiramate—obesity	0.000134	0.000668	CcSEcCtD
Ipratropium bromide—Insomnia—Topiramate—obesity	0.000133	0.000663	CcSEcCtD
Ipratropium bromide—Paraesthesia—Topiramate—obesity	0.000132	0.000659	CcSEcCtD
Ipratropium bromide—Dyspnoea—Topiramate—obesity	0.000131	0.000654	CcSEcCtD
Ipratropium bromide—Somnolence—Topiramate—obesity	0.000131	0.000652	CcSEcCtD
Ipratropium bromide—Dyspepsia—Topiramate—obesity	0.00013	0.000646	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Topiramate—obesity	0.000127	0.000633	CcSEcCtD
Ipratropium bromide—Fatigue—Topiramate—obesity	0.000127	0.000632	CcSEcCtD
Ipratropium bromide—Pain—Topiramate—obesity	0.000126	0.000627	CcSEcCtD
Ipratropium bromide—Constipation—Topiramate—obesity	0.000126	0.000627	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Topiramate—obesity	0.00012	0.0006	CcSEcCtD
Ipratropium bromide—Urticaria—Topiramate—obesity	0.000117	0.000583	CcSEcCtD
Ipratropium bromide—Abdominal pain—Topiramate—obesity	0.000116	0.00058	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Topiramate—obesity	0.000109	0.00054	CcSEcCtD
Ipratropium bromide—Asthenia—Topiramate—obesity	0.000106	0.000526	CcSEcCtD
Ipratropium bromide—Pruritus—Topiramate—obesity	0.000104	0.000519	CcSEcCtD
Ipratropium bromide—Diarrhoea—Topiramate—obesity	0.000101	0.000502	CcSEcCtD
Ipratropium bromide—Dizziness—Topiramate—obesity	9.74e-05	0.000485	CcSEcCtD
Ipratropium bromide—Vomiting—Topiramate—obesity	9.36e-05	0.000466	CcSEcCtD
Ipratropium bromide—Rash—Topiramate—obesity	9.29e-05	0.000463	CcSEcCtD
Ipratropium bromide—Dermatitis—Topiramate—obesity	9.28e-05	0.000462	CcSEcCtD
Ipratropium bromide—Headache—Topiramate—obesity	9.23e-05	0.00046	CcSEcCtD
Ipratropium bromide—Nausea—Topiramate—obesity	8.75e-05	0.000436	CcSEcCtD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CD—obesity	6.55e-06	4.88e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPIN1—obesity	6.52e-06	4.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PIK3CA—obesity	6.49e-06	4.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SERPINE1—obesity	6.48e-06	4.82e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA5—obesity	6.39e-06	4.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRKCD—obesity	6.39e-06	4.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRKCD—obesity	6.37e-06	4.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRKCD—obesity	6.31e-06	4.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TYK2—obesity	6.3e-06	4.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GCG—obesity	6.3e-06	4.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC2A4—obesity	6.3e-06	4.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CG—obesity	6.25e-06	4.66e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—obesity	6.25e-06	4.66e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RHOA—obesity	6.25e-06	4.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—C3—obesity	6.24e-06	4.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—obesity	6.23e-06	4.64e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—C3—obesity	6.22e-06	4.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYCS—obesity	6.22e-06	4.63e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3R1—obesity	6.18e-06	4.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOS3—obesity	6.18e-06	4.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—obesity	6.17e-06	4.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—C3—obesity	6.16e-06	4.59e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GGT1—obesity	6.1e-06	4.54e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GOT1—obesity	6.1e-06	4.54e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CLOCK—obesity	6.1e-06	4.54e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC22A1—obesity	6.1e-06	4.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARG—obesity	6.03e-06	4.5e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NCOA1—obesity	6.01e-06	4.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—POMC—obesity	5.95e-06	4.43e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SULT2A1—obesity	5.94e-06	4.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GLP1R—obesity	5.94e-06	4.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS2—obesity	5.94e-06	4.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGT—obesity	5.93e-06	4.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP19A1—obesity	5.92e-06	4.41e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—STK11—obesity	5.92e-06	4.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS2—obesity	5.92e-06	4.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—INS—obesity	5.92e-06	4.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGT—obesity	5.91e-06	4.4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PIK3CA—obesity	5.89e-06	4.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS2—obesity	5.86e-06	4.37e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGT—obesity	5.85e-06	4.36e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—DPYD—obesity	5.84e-06	4.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOE—obesity	5.81e-06	4.33e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LEP—obesity	5.81e-06	4.33e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LEP—obesity	5.79e-06	4.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOE—obesity	5.79e-06	4.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CAV1—obesity	5.76e-06	4.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOA1—obesity	5.74e-06	4.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CAV1—obesity	5.74e-06	4.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LEP—obesity	5.74e-06	4.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOE—obesity	5.74e-06	4.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOA1—obesity	5.73e-06	4.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CB—obesity	5.71e-06	4.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MTOR—obesity	5.71e-06	4.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CAV1—obesity	5.68e-06	4.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOA1—obesity	5.67e-06	4.22e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PRKAR2B—obesity	5.63e-06	4.19e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—DCN—obesity	5.58e-06	4.16e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ESR1—obesity	5.55e-06	4.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ESR1—obesity	5.53e-06	4.12e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—COMT—obesity	5.5e-06	4.1e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CD—obesity	5.5e-06	4.09e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRKCB—obesity	5.48e-06	4.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—F2—obesity	5.48e-06	4.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ESR1—obesity	5.48e-06	4.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—F2—obesity	5.46e-06	4.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRKCB—obesity	5.46e-06	4.07e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CPT1A—obesity	5.43e-06	4.05e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GNB3—obesity	5.43e-06	4.04e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARGC1A—obesity	5.43e-06	4.04e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—obesity	5.43e-06	4.04e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—BAD—obesity	5.42e-06	4.03e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRKCB—obesity	5.41e-06	4.03e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—F2—obesity	5.41e-06	4.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—obesity	5.4e-06	4.02e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—BAD—obesity	5.4e-06	4.02e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—BAD—obesity	5.35e-06	3.98e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NAMPT—obesity	5.33e-06	3.97e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT1—obesity	5.3e-06	3.95e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LIPC—obesity	5.29e-06	3.94e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCK—obesity	5.29e-06	3.94e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GNAS—obesity	5.28e-06	3.94e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOC3—obesity	5.26e-06	3.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CG—obesity	5.24e-06	3.91e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CG—obesity	5.23e-06	3.89e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—obesity	5.22e-06	3.89e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3R1—obesity	5.19e-06	3.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NOS3—obesity	5.19e-06	3.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS1—obesity	5.18e-06	3.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CG—obesity	5.18e-06	3.86e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOB—obesity	5.18e-06	3.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS1—obesity	5.17e-06	3.85e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS1—obesity	5.12e-06	3.81e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CETP—obesity	5.11e-06	3.81e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SDC1—obesity	5.05e-06	3.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—POMC—obesity	4.99e-06	3.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—POMC—obesity	4.98e-06	3.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKR1C3—obesity	4.97e-06	3.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—INS—obesity	4.96e-06	3.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—obesity	4.96e-06	3.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—INS—obesity	4.95e-06	3.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LPL—obesity	4.94e-06	3.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—POMC—obesity	4.93e-06	3.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—INS—obesity	4.9e-06	3.65e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SCARB1—obesity	4.89e-06	3.64e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL2—obesity	4.88e-06	3.64e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL2—obesity	4.87e-06	3.63e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK8—obesity	4.82e-06	3.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL2—obesity	4.82e-06	3.59e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—obesity	4.82e-06	3.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT1—obesity	4.81e-06	3.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1—obesity	4.8e-06	3.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT2—obesity	4.8e-06	3.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CB—obesity	4.79e-06	3.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1—obesity	4.79e-06	3.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT2—obesity	4.78e-06	3.56e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SREBF1—obesity	4.75e-06	3.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—obesity	4.75e-06	3.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1—obesity	4.74e-06	3.53e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT2—obesity	4.74e-06	3.53e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CD36—obesity	4.7e-06	3.5e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GOT2—obesity	4.62e-06	3.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CD—obesity	4.61e-06	3.43e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CD—obesity	4.6e-06	3.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CA—obesity	4.57e-06	3.4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SERPINE1—obesity	4.56e-06	3.4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CA—obesity	4.55e-06	3.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CD—obesity	4.55e-06	3.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SERPINE1—obesity	4.55e-06	3.39e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—FASN—obesity	4.52e-06	3.37e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CA—obesity	4.51e-06	3.36e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—BCHE—obesity	4.5e-06	3.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SERPINE1—obesity	4.5e-06	3.35e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—obesity	4.45e-06	3.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TYK2—obesity	4.44e-06	3.3e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TYK2—obesity	4.42e-06	3.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—STAT3—obesity	4.41e-06	3.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RHOA—obesity	4.4e-06	3.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RHOA—obesity	4.38e-06	3.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TYK2—obesity	4.38e-06	3.26e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARA—obesity	4.37e-06	3.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3R1—obesity	4.35e-06	3.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOS3—obesity	4.35e-06	3.24e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2E1—obesity	4.34e-06	3.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RHOA—obesity	4.34e-06	3.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3R1—obesity	4.34e-06	3.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOS3—obesity	4.34e-06	3.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOS3—obesity	4.3e-06	3.2e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3R1—obesity	4.3e-06	3.2e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NQO1—obesity	4.29e-06	3.2e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AGT—obesity	4.23e-06	3.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CA—obesity	4.15e-06	3.09e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOE—obesity	4.14e-06	3.09e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CA—obesity	4.13e-06	3.08e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCG—obesity	4.12e-06	3.07e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A4—obesity	4.12e-06	3.07e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CAV1—obesity	4.1e-06	3.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—obesity	4.1e-06	3.05e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOA1—obesity	4.09e-06	3.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CA—obesity	4.09e-06	3.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—obesity	4.09e-06	3.05e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYCS—obesity	4.06e-06	3.03e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CB—obesity	4.02e-06	2.99e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MTOR—obesity	4.02e-06	2.99e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CB—obesity	4.01e-06	2.98e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MTOR—obesity	4.01e-06	2.98e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GGT1—obesity	3.99e-06	2.97e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GOT1—obesity	3.99e-06	2.97e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CB—obesity	3.97e-06	2.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MTOR—obesity	3.97e-06	2.96e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NCOA1—obesity	3.93e-06	2.93e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—STK11—obesity	3.87e-06	2.88e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP19A1—obesity	3.87e-06	2.88e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CG—obesity	3.74e-06	2.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT1—obesity	3.73e-06	2.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT1—obesity	3.72e-06	2.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT1—obesity	3.68e-06	2.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—obesity	3.67e-06	2.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—obesity	3.66e-06	2.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—obesity	3.62e-06	2.7e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARG—obesity	3.61e-06	2.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—COMT—obesity	3.6e-06	2.68e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—POMC—obesity	3.56e-06	2.65e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GNB3—obesity	3.55e-06	2.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARGC1A—obesity	3.55e-06	2.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—INS—obesity	3.54e-06	2.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—obesity	3.53e-06	2.63e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—obesity	3.49e-06	2.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—obesity	3.48e-06	2.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CA—obesity	3.48e-06	2.59e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GNAS—obesity	3.46e-06	2.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—obesity	3.45e-06	2.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK8—obesity	3.4e-06	2.53e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT1—obesity	3.39e-06	2.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK8—obesity	3.39e-06	2.52e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOB—obesity	3.38e-06	2.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT1—obesity	3.38e-06	2.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK8—obesity	3.35e-06	2.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT1—obesity	3.34e-06	2.49e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CD—obesity	3.29e-06	2.45e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—obesity	3.24e-06	2.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPL—obesity	3.23e-06	2.41e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—obesity	3.15e-06	2.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—STAT3—obesity	3.11e-06	2.31e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NOS3—obesity	3.1e-06	2.31e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3R1—obesity	3.1e-06	2.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—STAT3—obesity	3.1e-06	2.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—obesity	3.08e-06	2.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CD36—obesity	3.07e-06	2.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—STAT3—obesity	3.07e-06	2.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CA—obesity	2.92e-06	2.18e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—obesity	2.91e-06	2.17e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—obesity	2.89e-06	2.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—obesity	2.88e-06	2.14e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—obesity	2.88e-06	2.14e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—obesity	2.87e-06	2.14e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CB—obesity	2.86e-06	2.13e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARA—obesity	2.85e-06	2.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—obesity	2.85e-06	2.12e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT1—obesity	2.84e-06	2.12e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—obesity	2.84e-06	2.12e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—obesity	2.84e-06	2.11e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AGT—obesity	2.76e-06	2.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOE—obesity	2.71e-06	2.02e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CAV1—obesity	2.68e-06	2e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA1—obesity	2.68e-06	1.99e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CA—obesity	2.45e-06	1.82e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CG—obesity	2.44e-06	1.82e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CA—obesity	2.44e-06	1.82e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CA—obesity	2.42e-06	1.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKT1—obesity	2.39e-06	1.78e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARG—obesity	2.36e-06	1.76e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—POMC—obesity	2.33e-06	1.73e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—INS—obesity	2.31e-06	1.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—obesity	2.17e-06	1.62e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—obesity	2.16e-06	1.61e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CD—obesity	2.15e-06	1.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—obesity	2.14e-06	1.6e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—obesity	2.12e-06	1.58e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3R1—obesity	2.03e-06	1.51e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NOS3—obesity	2.03e-06	1.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT1—obesity	2e-06	1.49e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT1—obesity	1.99e-06	1.49e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT1—obesity	1.98e-06	1.47e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CB—obesity	1.87e-06	1.4e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—obesity	1.86e-06	1.38e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CA—obesity	1.75e-06	1.3e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKT1—obesity	1.43e-06	1.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CA—obesity	1.14e-06	8.5e-06	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKT1—obesity	9.33e-07	6.95e-06	CbGpPWpGaD
